Related Experiment Video
Updated: Jul 20, 2026
11:16
A Novel Procedure for Evaluating the Reinforcing Properties of Tastants in Laboratory Rats: Operant Intraoral Self-administration
Published on: February 6, 2014
Pharmacology of ingestive behaviour
1Istituto di Ricerche Farmacologiche, Mario Negri, Milano, Italy.
Therapie
|March 1, 1996
Summary
Specific catecholamine and serotonin receptor subtypes regulate feeding behavior. Research shows certain receptors (e.g., beta 1/2-adrenoceptors, D1 dopamine, 5-HT1B/2C) reduce feeding, while 5-HT2A receptors impact stress-related eating.
Area of Science:
- Neuroscience
- Pharmacology
- Physiology
Background:
- Feeding control involves complex neurochemical pathways.
- Catecholamines and serotonin are key neurotransmitters influencing appetite and satiety.
- Understanding specific receptor subtypes is crucial for targeted interventions.
Purpose of the Study:
- To review current research on catecholamine and serotonin receptor subtypes in feeding regulation.
- To identify specific receptor subtypes involved in reducing feeding and enhancing satiety.
- To explore the interplay between serotonin, cholecystokinin, and stress-induced feeding.
Main Methods:
- Review of existing scientific literature and research findings.
- Analysis of studies investigating the effects of receptor stimulation on feeding behavior in animal models (rats).
- Examination of neurochemical mechanisms, including neurotransmitter interactions and neuropeptide signaling.
Main Results:
- Specific catecholamine receptors (beta 1/2-adrenoceptors, alpha 1-adrenoceptors) and D1 dopamine receptors reduce feeding.
- Serotonin receptors 5-HT1B and 5-HT2C decrease feeding and may increase satiety.
- Serotonin 5-HT2A receptors modulate stress-induced anorexia and neuropeptide Y-induced hyperphagia, potentially via corticotropin-releasing factor.
Conclusions:
- Specific catecholamine and serotonin receptor subtypes play distinct roles in regulating feeding behavior.
- Findings contribute to understanding the neurobiology of appetite and satiety.
- These insights may advance the pharmacotherapy for obesity and eating disorders.
Related Concept Videos
01:14Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...